topical ruxolitinib 1.5% cream: Clinical Trials

2 trials of topical ruxolitinib 1.5% cream, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Recruiting 1

Follow topical ruxolitinib 1.5% cream: new trials by email Literature Review of topical ruxolitinib 1.5% cream trials Research Report on topical ruxolitinib 1.5% cream

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum
topical ruxolitinib 1.5% cream - Pyoderma Gangrenosum
Phase 2RecruitingOregon Health and Science University122026-09-012026-10-09
Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease
topical ruxolitinib 1.5% cream, Topical vehicle/moisturizer cream - Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center242019-05-142026-07-10

Conditions studied

Pyoderma Gangrenosum (1)  ·  Wounds and Injuries (1)

Sponsors

Memorial Sloan Kettering Cancer Center (1)  ·  Oregon Health and Science University (1)

Countries

United States (2)

Top investigators

Alina Markova, MD (1)

Results publications

PMID 42748944